Robin, Fabien
Angenard, Gaëlle
Cano, Luis
Courtin-Tanguy, Laetitia
Gaignard, Elodie
Khene, Zine-Eddine
Bergeat, Damien
Clément, Bruno
Boudjema, Karim
Coulouarn, Cédric
Sulpice, Laurent
Article History
Received: 7 January 2020
Revised: 22 March 2020
Accepted: 9 April 2020
First Online: 7 May 2020
Ethics approval and consent to participate
: The study protocol fulfilled national laws and regulations in accordance with the Declaration of Helsinki and was approved by the Rennes University Hospital Ethics Committee (Rennes, France). Written informed consent was obtained from all patients included in the study.
: The data sets generated during and/or analysed during this study are available from the corresponding author on reasonable request.
: The authors declare no competing interests.
: This work was supported by Inserm, Université de Rennes 1, INCa, ITMO Cancer AVIESAN (Alliance Nationale pour les Sciences de la Vie et de la Santé) dans le cadre du Plan cancer (Non-coding RNA in cancerology: fundamental to translational) (to C.C.), Novartis and Novartis Oncology (to L.S.).